Alternative Data for Idexx Laboratories
| Alternative Data | Value | 3m Change | Trend | Benchmark | |
|---|---|---|---|---|---|
| Job Posts | 202 | Sign up | Sign up | Sign up | |
| Sentiment | 92 | Sign up | Sign up | Sign up | |
| Webpage traffic | 644,000 | Sign up | Sign up | Sign up | |
| Employee Rating | 68 | Sign up | Sign up | Sign up | |
| Google Trends | N/A | Sign up | Sign up | Sign up | |
| Patents | N/A | Sign up | Sign up | Sign up | |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up | |
| Facebook Engagement | 2,591 | Sign up | Sign up | Sign up | |
| Facebook Followers | 132,460 | Sign up | Sign up | Sign up | |
| Instagram Followers | 22,194 | Sign up | Sign up | Sign up | |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up | |
| Stocktwits Subscribers | 2,946 | Sign up | Sign up | Sign up | |
| X Followers | 265 | Sign up | Sign up | Sign up | |
| X Mentions | 3 | Sign up | Sign up | Sign up | |
| Youtube Subscribers | 5,610 | Sign up | Sign up | Sign up | |
| News Mentions | N/A | Sign up | Sign up | Sign up | |
| Customer reviews | N/A | Sign up | Sign up | Sign up | |
| Business Outlook | 57 | Sign up | Sign up | Sign up | |
| Linkedin Employees | 7,867 | Sign up | Sign up | Sign up |
About Idexx Laboratories
Maine-based IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments.
| Price | $694.75 |
| Target Price | Sign up |
| Volume | 415,820 |
| Market Cap | $55.5B |
| Year Range | $500.87 - $766.68 |
| Dividend Yield | 0% |
| PE Ratio | 54.94 |
| Analyst Rating | 57% buy |
| Earnings Date | February 2 '26 |
| Industry | Health Care Services |
In the news
![]() |
How IDEXX’s Diagnostics-Focused CEO Transition At IDEXX Laboratories (IDXX) Has Changed Its Investment StoryJanuary 13 - Yahoo |
IDEXX Laboratories (IDXX): From a Detractor to a RevivorJanuary 13 - Yahoo Entertainment |
|
![]() |
Is It Too Late To Consider Buying IDEXX Laboratories (IDXX) After A 71% One Year RallyJanuary 9 - Yahoo |
![]() |
IBD Stock Of The Day: Pet-Health Firm Idexx Laboratories Looks To Build On 2025 RallyJanuary 9 - Yahoo |
![]() |
Conestoga Mid Cap Composite Q4 2025 Leaders And LaggardsJanuary 24 - SeekingAlpha |
Monoclonal Antibodies in Veterinary Health Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031January 23 - GlobeNewswire |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 1.11B | 422M | 683M | 275M | 392M | 3.400 |
| Q2 '25 | 1.11B | 415M | 695M | 294M | 409M | 3.630 |
| Q1 '25 | 998M | 375M | 623M | 243M | 352M | 2.960 |
| Q4 '24 | 954M | 384M | 571M | 216M | 299M | 2.620 |
| Q3 '24 | 976M | 380M | 596M | 233M | 342M | 2.800 |
Insider Transactions View All
| Hunt Nimrata filed to sell 25,460 shares at $702.2. November 10 '25 |
| Hunt Nimrata filed to sell 22,527 shares at $704.9. November 10 '25 |
| Hunt Nimrata filed to sell 23,995 shares at $703.7. November 10 '25 |
| Hunt Nimrata filed to sell 21,149 shares at $705.5. November 10 '25 |
| SZOSTAK M ANNE filed to sell 262 shares at $647.3. August 26 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| April Delaney |
Jan 6, 26 | Sell | $1K - $15K |
| April Delaney |
Nov 5, 25 | Sell | $1K - $15K |
| April Delaney |
Nov 5, 25 | Sell | $1K - $15K |
Read more about Idexx Laboratories (IDXX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Idexx Laboratories
The Market Cap of Idexx Laboratories is $55.5B.
As of today, Idexx Laboratories' PE (Price to Earnings) ratio is 54.94.
Idexx Laboratories will report its next earnings on February 2 '26.
Currently, the price of one share of Idexx Laboratories stock is $694.75.
The IDXX stock price chart above provides a comprehensive visual representation of Idexx Laboratories' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Idexx Laboratories shares. Our platform offers an up-to-date IDXX stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Idexx Laboratories (IDXX) does not offer dividends to its shareholders. Investors interested in Idexx Laboratories should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Idexx Laboratories are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and LabCorp.






